相关实验视频
Updated: Jun 30, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
569
阿尔茨海默病和临床试验
Deepraj Paul1, Rohini Agrawal1, Swati Singh1
1Department of Pharmacology, 621320 College of Pharmacy JSS Academy of Technical Education , Noida, Uttar Pradesh, India.
Journal of basic and clinical physiology and pharmacology
|March 16, 2024
概括
阿尔茨海默病药物试验面临挑战,原因是确定了候选药物的局限性,如提乙和crenezumab. 临床研究的预先评估对于防止试验失败和节约资源至关重要.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学是一种遗传学.
背景情况:
- 阿尔茨海默病 (AD) 是一个日益严重的全球健康问题,具有许多已识别的遗传特征.
- 尽管针对AD相关基因进行了广泛的研究和临床试验,但许多药物发现努力都失败了.
研究的目的:
- 在临床试验中审查和确定候选药物的局限性 (thiethylperazine,CT1812,crenezumab,CNP520,lecanemab).
- 分析可能阻碍临床试验成功的交叉谈话途径中的混因素.
主要方法:
- 研究文献综述和关于阿尔茨海默病候选药物的评论文章.
- 对特定候选药物的确定的局限性和混因素的分析.
主要成果:
- 一些候选药物,包括提乙氨酸,CT1812,crenezumab和CNP520,尽管正在临床试验中,但仍存在显著的局限性.
- 交叉谈话途径分析揭示了可能对试验结果产生负面影响的混因素.
结论:
- 由于发现的局限性,将某些候选药物纳入临床试验的合理性受到质疑.
- 对临床研究结果的精心预先评估可以防止昂贵和资源密集的失败试验.
相关概念视频
Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
Alzheimer's Disease: Treatment
186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K

